NCT07461987 Tai Chi and Square-Stepping Exercises in Women With Multiple Sclerosis
| NCT ID | NCT07461987 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Pamukkale University |
| Condition | Multiple Sclerosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 39 participants |
| Start Date | 2026-02-15 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 39 participants in total. It began in 2026-02-15 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Tai Chi is an exercise approach consisting of slow and controlled movements, whereas square stepping exercises are an exercise method in which specific step patterns are followed. The aim of this study is to comparatively examine the effects of Tai Chi and Square Stepping Exercises on knee joint position sense, lower extremity muscle strength, and fatigue levels in women with multiple sclerosis.
Eligibility Criteria
Inclusion Criteria: * Willing to participate and provide informed consent. * Diagnosed with multiple sclerosis (MS) according to the McDonald diagnostic criteria. * Relapsing-remitting MS (RRMS) phenotype. * EDSS score \< 3.5. * Female, 20-45 years of age. * No MS relapse within the past 1 month. * No lower-extremity spasticity according to the Modified Ashworth Scale (MAS). Exclusion Criteria: * Any neurological disease other than MS. * Experiencing an MS relapse during the study period. * History of orthopedic surgery that may affect balance. * Cognitive or psychiatric impairment that may interfere with study participation. * Cardiovascular or pulmonary history that may prevent participation. * Use of medications that may affect clinical assessment (e.g., antipsychotic use; continuous corticosteroid or immunosuppressive use within the past 1 month). * Participation in any other exercise program
Contact & Investigator
Müge İçelli Güneş, PhD
PRINCIPAL INVESTIGATOR
Pamukkale University Denizli Health Services Vocational School of Higher Education
Frequently Asked Questions
Who can join the NCT07461987 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 45 Years, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07461987 currently recruiting?
Yes, NCT07461987 is actively recruiting participants. Contact the research team at micelli@pau.edu.tr for enrollment information.
Where is the NCT07461987 trial being conducted?
This trial is being conducted at Denizli, Turkey (Türkiye).
Who is sponsoring the NCT07461987 clinical trial?
NCT07461987 is sponsored by Pamukkale University. The principal investigator is Müge İçelli Güneş, PhD at Pamukkale University Denizli Health Services Vocational School of Higher Education. The trial plans to enroll 39 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.